Biogen Scraps 2 More Studies In Alzheimer’s Disease — And Shares Pop

Biogen stock popped in relief Friday after the biotech company scrapped several tests in Alzheimer's treatment for a drug known as elenbecestat. It was being developed with…… Read more “Biogen Scraps 2 More Studies In Alzheimer’s Disease — And Shares Pop”